First real-world observational study of the JADA®System, a medical device to control postpartum hemorrhage (PPH), published in ACOG’s Obstetrics & Gynecology

Organon today announced that Obstetrics & Gynecology, the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), published the results of the RUBY study which reached its primary effectiveness outcome of successfully treating abnormal postpartum uterine bleeding and postpartum hemorrhage with the JADA® System.

Heart Disease: Still the Silent Killer Despite Prevention Options

John Auerbach, SVP Federal Health, ICF Given the attention paid to the devastating impact of COVID-19, one might assume it was the leading cause of

April 2, 2024

Statins linked to slight diabetes risk but benefits outweigh the concerns

Statin use is associated with a moderate, dose-dependent increase in the risk of new-onset diabetes, particularly in individuals close to the diabetes threshold, yet the

March 29, 2024

New small molecule offers hope in combating antibiotic resistance

Researchers from the University of Oxford have developed a new small molecule that can suppress the evolution of antibiotic resistance in bacteria and make resistant

May 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.